Sun, 01 Nov 2026
01:14:30 pm
Rudransh Sangwan
Published at: September 17, 2026, 8:50 AM
Synopsis
NHC Foods shares hit the upper circuit after acquisition plans for Lotmor Brands and Walya’s Beverages. See the deal details and financial performance.

NHC Foods shares hit the 5% upper circuit on September 17 after the company announced plans to acquire controlling stakes in two food and beverage companies, Lotmor Brands and Walya’s Beverages.
The proposed transactions would give NHC Foods up to 88% of Lotmor Brands and up to 80% of Walya’s Beverages. The company said the acquisitions are aimed at expanding its presence across the food and beverage value chain.
Loading chart...
| Metric | Details |
|---|---|
| Previous close | Rs 2.01 |
| Intraday high | Rs 2.11 |
| Intraday move | 5% |
| Market capitalisation | Around Rs 198 crore |
| 1 year return | Around 88% |
The stock reached Rs 2.11 during Thursday's session, compared with its previous close of Rs 2.01.
| Company | Proposed stake | Consideration |
|---|---|---|
| Lotmor Brands | Up to 88% | Rs 6.50 per share |
| Walya’s Beverages | Up to 80% | Rs 6.50 per share |
The consideration can be paid in cash or through the issue of NHC Foods equity shares at Rs 6.50 per share. The company has also stated that the price may be determined after six months in accordance with SEBI ICDR regulations.
Lotmor Brands operates across food and beverage trading, manufacturing and distribution. It has a presence across more than 20 states and around 22,000 retail outlets, including partnerships with Reliance Smart, D Mart and quick commerce platforms.
Walya’s Beverages operates across manufacturing, trading, wholesaling, import and export of food and beverage products. Its FY25 turnover was reported at around Rs 0.22 crore. Lotmor Brands reported FY25 turnover of around Rs 1.8 crore.
The acquisitions could broaden NHC Foods beyond its existing agricultural commodity processing and trading operations. The company plans to integrate the acquired businesses with its existing sourcing, processing and distribution capabilities.
NHC Foods Managing Director Satyam Shirishchandra Joshi said the company intends to build links between sourcing, processing, distribution and end markets rather than operate the businesses separately.
The company had also signed an MoU with Lotmor in July 2025 regarding potential manufacturing rights for beverages and similar products, indicating that its interest in the beverage segment predates the latest acquisition proposal.
| Metric | Q1 FY26 | Q1 FY27 | Growth |
|---|---|---|---|
| Revenue | Rs 111 Cr | Rs 370 Cr | 235% |
| EBITDA | Rs 3.39 Cr | Rs 20.9 Cr | 515% |
| Net profit | Rs 1.66 Cr | Rs 17 Cr | 931% |
The sharp improvement in quarterly financial performance has added to investor attention around the company. However, the proposed acquisitions are still subject to the relevant completion conditions and should be assessed separately from the reported quarterly results.
Investors will track the final transaction terms, funding method, integration of the acquired businesses and their contribution to NHC Foods' revenue and profitability.
The company has also been expanding its capital base and has entered into a binding Heads of Terms for a proposed manufacturing facility in Liberia, adding further expansion plans to its business strategy.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Motilal Oswal Q2 FY27 results show net profit rising 198% to ₹1,080 crore, revenue increasing 64% to ₹3,040 crore and EBITDA margin reaching 60.37%.

Bliss GVS Pharma Q2 FY27 results show revenue rising 37.3% to ₹261.13 crore, EBITDA jumping 161.4% and net profit increasing 196%.

Alivus Life Sciences Q2 FY27 results show net profit rising 51.3% to ₹196.8 crore, revenue growing 16% to ₹682 crore and EBITDA margin reaching 38.

Thyrocare Q2 FY27 revenue rose 25.1% to ₹270.81 crore, while net profit fell 66.9% to ₹15.89 crore amid a ₹44.98 crore impairment loss.

Patel Retail will invest ₹2 crore to add 20,000 sq ft to its Ambernath distribution centre, increasing covered area to 84,000 sq ft.